Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Observational StudyRegistry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Sponsor:

Novartis Pharmaceuticals

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-25. This information was provided to ClinicalTrials.gov by Novartis Pharmaceuticals on 2025-01-31.